These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 12696775)
1. Efficacy and tolerability of piroxicam-beta-cyclodextrin in the outpatient management of chronic back pain. Pijak MR; Turcani P; Turcaniova Z; Buran I; Gogolak I; Mihal A; Gazdik F Bratisl Lek Listy; 2002; 103(12):467-72. PubMed ID: 12696775 [TBL] [Abstract][Full Text] [Related]
2. Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease. Reginster JY; Franchimont P Eur J Rheumatol Inflamm; 1993; 12(4):38-46. PubMed ID: 7805703 [TBL] [Abstract][Full Text] [Related]
3. [Analgesic efficacy and the tolerance for piroxicam-beta-cyclodextrin compared to piroxicam, paracetamol and placebo in the treatment of postextraction dental pain]. Dolci G; Ripari M; Pacifici L; Umile A Minerva Stomatol; 1993 May; 42(5):235-41. PubMed ID: 8413108 [TBL] [Abstract][Full Text] [Related]
4. Piroxicam fast-dissolving dosage form in the treatment of patients with acute low back pain. Englert R; Fontanesi G; Müller P; Ott H; Rehn L; Silva H Clin Ther; 1996; 18(5):843-52. PubMed ID: 8930428 [TBL] [Abstract][Full Text] [Related]
6. Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states. Lee CR; Balfour JA Drugs; 1994 Dec; 48(6):907-29. PubMed ID: 7533698 [TBL] [Abstract][Full Text] [Related]
7. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract. Warrington S Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701 [TBL] [Abstract][Full Text] [Related]
8. Effects of piroxicam-beta-cyclodextrin sachets on abnormal postural sway in patients with chronic low back pain. Chang ST; Chen LC; Chang CC; Chu HY; Tsai KC J Clin Pharm Ther; 2008 Oct; 33(5):495-506. PubMed ID: 18834364 [TBL] [Abstract][Full Text] [Related]
9. Piroxicam-β-cyclodextrin: a GI safer piroxicam. Scarpignato C Curr Med Chem; 2013; 20(19):2415-37. PubMed ID: 23394552 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and gastrointestinal tolerability of beta-cyclodextrin-piroxicam and tenoxicam in the treatment of chronic osteoarthritis. Bonardelli P; Oliani C; Monici Preti PA; Pellicanó P; Quattrocchi G Clin Ther; 1990; 12(6):547-55. PubMed ID: 2289222 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of piroxicam-beta-cyclodextrin, piroxicam, paracetamol and placebo in post-operative oral surgery pain. Dolci G; Ripari M; Pacifici L; Umile A Int J Clin Pharmacol Res; 1994; 14(5-6):185-91. PubMed ID: 7672875 [TBL] [Abstract][Full Text] [Related]
12. Lornoxicam efficacy in acute pain (LEAP) trial. Sharma A; Pingle A; Baliga VP J Indian Med Assoc; 2008 Dec; 106(12):811-3. PubMed ID: 19370957 [TBL] [Abstract][Full Text] [Related]
13. [Beta-cyclodextrin-piroxicam in the treatment of the active phase of osteoarthritic pathology]. La Montagna G; Parenti M; Oliani C; Filippi F; Tirri G Riv Eur Sci Med Farmacol; 1990; 12(4-5):265-72. PubMed ID: 2103967 [TBL] [Abstract][Full Text] [Related]
15. [Osteoarthritic disease: therapy with oxicam derivatives]. Abate G; Zito M; Guarino F; Di Peppe MC; Troya C Riv Eur Sci Med Farmacol; 1990; 12(4-5):273-81. PubMed ID: 2103968 [TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the antalgic activity and tolerability of piroxicam in chronic pain in cervicoarthrosis and lumboarthrosis]. Minisola G; Dardano B Clin Ter; 1989 Oct; 131(2):73-82. PubMed ID: 2533023 [TBL] [Abstract][Full Text] [Related]
17. [Chronic diarrhea due to lymphocytic colitis treated with piroxicam beta cyclodextrin]. Mennecier D; Gros P; Bronstein JA; Thiolet C; Farret O Presse Med; 1999 Apr; 28(14):735-7. PubMed ID: 10230409 [TBL] [Abstract][Full Text] [Related]
18. Macrocyclic molecules and their pharmacological applications. Lasagna L Eur J Rheumatol Inflamm; 1993; 12(4):3-5. PubMed ID: 7805702 [No Abstract] [Full Text] [Related]
19. Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration. Patoia L; Clausi G; Farroni F; Alberti P; Fugiani P; Bufalino L Eur J Clin Pharmacol; 1989; 36(6):599-604. PubMed ID: 2673795 [TBL] [Abstract][Full Text] [Related]
20. Piroxicam-beta-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men. Warrington S; Debbas N; Farthing M; Horton M; Umile A Int J Tissue React; 1991; 13(5):243-8. PubMed ID: 1806546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]